IP Verse

Ionis Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ionis Pharmaceuticals, Inc.

Patent Number:
EP2752488
Title:
Antisense Design
Applicant:
ROCHE INNOVATION CENTER COPENHAGEN A/S
Opposition Date:
Nov 12, 2020

Latest patents of Ionis Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP3400947
Grant Date:
Aug 23, 2023
Title:
Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations
Oppositions:
1
Patent:
EP2906696
Grant Date:
Dec 14, 2022
Title:
Methods For Modulating C9Orf72 Expression
Oppositions:
2
Patent:
EP3461895
Grant Date:
Jul 1, 2020
Title:
Modulation Of Ube3A-Ats Expression
Oppositions:
1
Patent:
EP2742135
Grant Date:
Jun 10, 2020
Title:
Linkage Modified Gapped Oligomeric Compounds And Uses Thereof
Oppositions:
1
Patent:
EP2399588
Grant Date:
Apr 29, 2020
Title:
Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase
Oppositions:
1
Patent:
EP3031920
Grant Date:
Aug 21, 2019
Title:
Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression
Oppositions:
1
Patent:
EP3208347
Grant Date:
Aug 14, 2019
Title:
Selective Reduction Of Allelic Variants
Oppositions:
1
Patent:
EP3321361
Grant Date:
Mar 27, 2019
Title:
Selective Reduction Of Allelic Variants
Oppositions:
1
Patent:
EP2640853
Grant Date:
Dec 26, 2018
Title:
Modulation Of Alpha Synuclein Expression
Oppositions:
1
Patent:
EP2864479
Grant Date:
Aug 15, 2018
Title:
Modulation Of Ube3A-Ats Expression
Oppositions:
1

Competitors of Ionis Pharmaceuticals, Inc.

ROCHE INNOVATION CENTER COPENHAGEN A/S

STRAWMAN LIMITED

HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

Want to track Ionis Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you